UnknownPhase 3NCT01138839
Dexamethasone Efficacy in HELLP I Syndrome
Studying HELLP syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universidad del Valle, Colombia
- Principal Investigator
- Javier Fonseca, DrUniversidad del Valle
- Intervention
- Dexamethasone(drug)
- Enrollment
- 160 target
- Eligibility
- 10-48 years · FEMALE
- Timeline
- 2009 – 2012
Study locations (1)
- Universidad del Valle, Cali, Valle del Cauca Department, Colombia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01138839 on ClinicalTrials.govOther trials for HELLP syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07151339Pilot Project Renal and Cardiovascular Tertiary Prevention in PreeclampsiaUniversity Hospital Schleswig-Holstein
- RECRUITINGNCT05500989PlacEntal Acute Atherosis RefLecting Subclinical AtherosclerosisMaastricht University Medical Center
- RECRUITINGNCT06377878The Preeclampsia RegistryPreeclampsia Foundation